Search research articles
Contact Us
Filters
Showing results (21-30 of 416) with videos related to
Page
of 42
Sort By:
Seminars in Oncology
|
September 29, 2018
Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option?
Sara Pilotto, Luisa Carbognin, Antonio Rossi, et al.
Expert Review of Anticancer Therapy
|
December 21, 2012
Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTOR
Alessandra Felici, Emilio Bria, Giampaolo Tortora, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 7, 2024
Tumor-Naïve Circulating Tumor DNA Detection Will Potentially Overturn the Strategy of Care in Early-Stage NSCLC
Filippo Lococo, Marco Chiappetta, Angelo Minucci, et al.
The Annals of Thoracic Surgery
|
October 6, 2014
Prognostic stratification of node-negative NSCLC patients: is it worthwhile?
Giovanni Leuzzi, Emilio Bria, Gabriele Alessandrini, et al.
Expert Opinion on Investigational Drugs
|
April 8, 2016
Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?
Luisa Carbognin, Sara Pilotto, Umberto Peretti, et al.
Eating and Weight Disorders : EWD
|
March 2, 2018
The obesity paradox in cancer: clinical insights and perspectives
Ilaria Trestini, Luisa Carbognin, Clelia Bonaiuto, et al.
European Journal of Internal Medicine
|
April 30, 2020
Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence
Giovanna Garufi, Luisa Carbognin, Armando Orlandi, et al.
Journal of the National Cancer Institute
|
January 18, 2007
Re: Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis
Emilio Bria, Paolo Carlini, Francesco Cognetti, et al.
Cureus
|
August 23, 2024
Lazarus Response to Selpercatinib for Bleeding Colic Metastasis in a Patient With RET Fusion-Positive Pulmonary Sarcomatoid Carcinoma: A Case Report
Federico Monaca, Emanuele Vita, Filippo Lococo, et al.
Critical Reviews in Oncology/Hematology
|
May 5, 2025
Evolving treatment for advanced non-small cell lung cancer harbouring common EGFR activating mutations
Igor Gomez-Randulfe, Federico Monaca, David Planchard, et al.
Page
of 42
Search research articles
Search
Showing results (21-30 of 416) with videos related to
Sort By:
Page
of 42
Seminars in Oncology
|
September 29, 2018
Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option?
Sara Pilotto, Luisa Carbognin, Antonio Rossi, et al.
Expert Review of Anticancer Therapy
|
December 21, 2012
Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTOR
Alessandra Felici, Emilio Bria, Giampaolo Tortora, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 7, 2024
Tumor-Naïve Circulating Tumor DNA Detection Will Potentially Overturn the Strategy of Care in Early-Stage NSCLC
Filippo Lococo, Marco Chiappetta, Angelo Minucci, et al.
The Annals of Thoracic Surgery
|
October 6, 2014
Prognostic stratification of node-negative NSCLC patients: is it worthwhile?
Giovanni Leuzzi, Emilio Bria, Gabriele Alessandrini, et al.
Expert Opinion on Investigational Drugs
|
April 8, 2016
Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?
Luisa Carbognin, Sara Pilotto, Umberto Peretti, et al.
Eating and Weight Disorders : EWD
|
March 2, 2018
The obesity paradox in cancer: clinical insights and perspectives
Ilaria Trestini, Luisa Carbognin, Clelia Bonaiuto, et al.
European Journal of Internal Medicine
|
April 30, 2020
Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence
Giovanna Garufi, Luisa Carbognin, Armando Orlandi, et al.
Journal of the National Cancer Institute
|
January 18, 2007
Re: Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis
Emilio Bria, Paolo Carlini, Francesco Cognetti, et al.
Cureus
|
August 23, 2024
Lazarus Response to Selpercatinib for Bleeding Colic Metastasis in a Patient With RET Fusion-Positive Pulmonary Sarcomatoid Carcinoma: A Case Report
Federico Monaca, Emanuele Vita, Filippo Lococo, et al.
Critical Reviews in Oncology/Hematology
|
May 5, 2025
Evolving treatment for advanced non-small cell lung cancer harbouring common EGFR activating mutations
Igor Gomez-Randulfe, Federico Monaca, David Planchard, et al.
Page
of 42